"The books that the world calls immoral are books that show the world its own shame.” ? Oscar Wilde, The Picture of Dorian Gray
Today, we revisit Verastem (VSTM), a small oncology outfit that comes up in comments from time to time. In early August, the company announced it has sold global development and commercialization rights to Copiktra (duvelisib) to Las Vegas, NV-based Secura Bio. This will allow Verastem to concentrate developing its RAF/MEK inhibitor VS-6766 and it FAK inhibitor program in KRAS mutation-positive solid tumors. This also means the company's market